Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged.
 
Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes.
 
We are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets.

Curve Therapeutics

Hard to believe it’s been a week already since my short, but excellent trip to Australia. A big thank you to the organisers of the International Peptide Symposium and the Australian Peptide Conference for the invitation to present research from the Tavassoli lab (University of Southampton) and Curve Therapeutics in Brisbane last week.

I really enjoyed reconnecting with peptide colleagues from around the world and hearing about all the latest exciting research in the peptide field. It was a fantastic touch by the organisers to give us the opportunity to meet the local wildlife during a conference lunch break.

Also, I am a Partner Investigator at the Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS), and really enjoyed the opportunity to reconnect with the CIPPS team, and to hear about all the excellent research arising from CIPPS. 

All in all, a fantastic few days that have left their mark: I've been singing Men at Work's Down Under since my return...

We’re #hiring a new Senior Scientist – Microfluidics in Southampton, England. Apply today or share this post with your network.

We are thrilled to welcome Dr Monika Ermann as our VP of Drug Discovery, and Profs. Julian Downward and Steven Benkovic to our Scientific Advisory Board. 

With our new facilities at Southampton Science Park, we are well positioned to expand our capabilities from the development of our Microcycle™ platform to the discovery of new drugs. 

https://lnkd.in/ePvCkBXY

Person Schema

Gravatar Profiles

Digital Ocean

Chief Executive Officer

Simon Kerry

Senior Scientist in Cell Biology

Cyrielle Doigneaux

Senior Scientist

Leonardo Baldassarre

VP Drug Discovery

Monika Ermann

Rab Prinjha

Chief R&D Officer

Companies With Fewer Than 100 Employees (Top 10K)

Europe Companies (Top 10K)

Europe, Middle East, and Africa (EMEA) Startups Founded in 2019

Europe, Middle East, and Africa (EMEA) Startups (Top 10K)

Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.

Pfizer Venture Investments

Series A - Curve Therapeutics

Southampton

United Kingdom

Europe

Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer

Curve Therapeutics adds to its leadership team

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Myricx Bio Archives

Southampton's Curve Therapeutics closes £40.5m funding round

Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment

Curve Therapeutics Raises £40.5M in Series A Funding

Pfizer Ventures leads £40.5m round in UK cancer drug discovery startup

UK biotech Curve swings £40.5m in Pfizer-backed round

Cancer-fighting BioTech Curve raises £40.5m

A mammalian cell platform technology for functional screening and enrichment of cyclic peptide libraries to identify biologically active molecules against therapeutic targets.

A non-peptidic, small-molecule drug in development that inhibits both HIF-1 and HIF-2, targeting survival mechanisms in solid tumours.

A first-in-class inhibitor targeting ATIC homodimerization, aimed at addressing vulnerabilities in multiple cancers.

Drugs in development targeting RAS-RAF mutations in aggressive and treatment-resistant cancers.

First-in-class FOXA1 inhibitors for the treatment of hormone refractory breast cancer.

India

Asia

Bangladesh

Germany

Mexico

North America

MSD is a global pharmaceutical company known for its innovative drug discovery and development.

Amazfit is a consumer electronics company that offers a range of health and fitness products, including smartwatches and fitness trackers.

Amazfit

Curve Therapeutics is a biopharmaceutical company focused on revolutionizing drug discovery through its intracellular screening platform to develop innovative therapeutics for challenging disease targets, particularly in the field of cancer.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 27, 2024 3:01 PM	00a1108b
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 27, 2024 3:01 PM	189f0a02
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	37e449b5
crunchbase profile	general	Nov 22, 2024 7:46 AM	a78ae16f
li profile	general	Feb 27, 2024 3:01 PM	280f338d
translate crunchbase fundingrounds	general	Nov 22, 2024 8:02 AM	2e8b6b4f
peers	general
news basic	general	Feb 27, 2024 3:01 PM	395a0738
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CURVETX

Curve Therapeutics